New metal hydride clusters provide insights into hydrogen storage

September 22, 2011

A study published by researchers at the RIKEN Advanced Science Institute (ASI) has shed first-ever light on a class of heterometallic molecular structures whose unique features point the way to breakthroughs in the development of lightweight fuel cell technology. The structures contain a previously-unexplored combination of rare-earth and d-transition metals ideally suited to the compact storage of hydrogen.

The most abundant element in the universe, hydrogen holds great promise as a source of clean, renewable energy, producing nothing but water as a byproduct and thus avoiding the environmental dangers associated with existing mainstream energy sources. Broad adoption of hydrogen, however, has stalled because in its natural gaseous state, the element simply takes up too much space to store and transport efficiently.

One way to solve this problem is to use metal hydrides, metallic compounds that incorporate , as a storage medium for hydrogen. In this technique, the metal hydrides bind to hydrogen to produce a solid one thousand times or more smaller than the original . The hydrogen can then later be released from the solid by heating it to a given temperature.

The new heterometallic hydride clusters synthesized by the RIKEN researchers use rare-earth and d-transition metals as building blocks and exploit the advantages of both. Rare earth metal hydrides remove one major obstacle by enabling analysis using X-ray diffraction, a technique which is infeasible for most other metal hydrides - offering unique insights into underlying reaction processes involved. Rare earth metal hydrides on their own, however, do not undergo reversible hydrogen addition and release, the cornerstone of hydrogen storage. This becomes possible through the addition of a d-transition metal, in this case tungsten (W) or molybdenum (Mo).

While rare-earth / d-transition metal-type metallic hydride complexes have been studied in the past, the current research is the first to explore complexes with multiple rare earth atoms of the form Ln4MHn and with well-defined structures (Ln = a rare-earth metal such as yttrium, M = a d-transition metal, either tungsten or molybdenum, and H = hydrogen). In a paper in Nature Chemistry, the researchers show that these complexes exhibit unique reactivity properties, pointing the way to new techniques and promising environmentally-friendly solutions to today's pressing energy needs.

Explore further: Hydrogen storage in nanoparticles works

Related Stories

Hydrogen storage in nanoparticles works

March 31, 2008

Dutch chemist Kees Baldé has demonstrated that hydrogen can be efficiently stored in nanoparticles. This allows hydrogen storage to be more easily used in mobile applications. Baldé discovered that 30 nanometre particles ...

Putting the squeeze on rare earth metals

April 15, 2011

(PhysOrg.com) -- Rare-earth metals are a series of elements that represent one of the final frontiers of chemical exploration. The vigorous reactivity of these substances, however, has made it difficult for researchers to ...

On the way to hydrogen storage?

April 19, 2011

(PhysOrg.com) -- The car of the future could be propelled by a fuel cell powered with hydrogen. But what will the fuel tank look like? Hydrogen gas is not only explosive but also very space-consuming. Storage in the form ...

Recommended for you

Brazilian wasp venom kills cancer cells by opening them up

September 1, 2015

The social wasp Polybia paulista protects itself against predators by producing venom known to contain a powerful cancer-fighting ingredient. A Biophysical Journal study published September 1 reveals exactly how the venom's ...

Naturally-occurring protein enables slower-melting ice cream

August 31, 2015

(Phys.org)—Scientists have developed a slower-melting ice cream—consider the advantages the next time a hot summer day turns your child's cone with its dream-like mound of orange, vanilla and lemon swirls with chocolate ...

Antibody-making bacteria promise drug development

August 31, 2015

Monoclonal antibodies, proteins that bind to and destroy foreign invaders in our bodies, routinely are used as therapeutic agents to fight a wide range of maladies including breast cancer, leukemia, asthma, arthritis, psoriasis, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.